Long-term outcomes and risk profile of cT3N0 breast cancer treated with neoadjuvant chemotherapy and curative surgery.
Young Seob ShinJae Ho JeongIl Yong ChungJaeha LeeSu Ssan KimSeung Do AhnJong Won LeeByung Ho SonJinhong JungPublished in: Journal of medical imaging and radiation oncology (2024)
Patients with cT3N0 breast cancer classified for rigorous pretreatment evaluation and treated with NAC and radical surgery had favourable oncological outcomes. A clinical risk group based on clinical and immunohistochemical risk factors was an excellent predictor of survival and recurrence.
Keyphrases
- neoadjuvant chemotherapy
- minimally invasive
- risk factors
- coronary artery bypass
- locally advanced
- computed tomography
- rectal cancer
- image quality
- contrast enhanced
- dual energy
- lymph node
- magnetic resonance imaging
- transcription factor
- free survival
- squamous cell carcinoma
- surgical site infection
- breast cancer risk
- early stage
- adipose tissue
- newly diagnosed
- radical prostatectomy
- percutaneous coronary intervention
- insulin resistance